Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Amedisys Inc (AMED)

Amedisys Inc (AMED)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,773,000
  • Shares Outstanding, K 32,255
  • Annual Sales, $ 1,663 M
  • Annual Income, $ 119,350 K
  • 60-Month Beta 1.48
  • Price/Sales 3.12
  • Price/Cash Flow 42.23
  • Price/Book 9.64

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.93
  • Number of Estimates 8
  • High Estimate 1.01
  • Low Estimate 0.88
  • Prior Year 0.91
  • Growth Rate Est. (year over year) +2.20%

Price Performance

See More
Period Period Low Period High Performance
1-Month
162.70 +10.01%
on 12/27/19
184.78 -3.14%
on 01/17/20
+16.43 (+10.11%)
since 12/24/19
3-Month
127.12 +40.80%
on 10/31/19
184.78 -3.14%
on 01/17/20
+45.39 (+33.98%)
since 10/24/19
52-Week
106.65 +67.82%
on 05/20/19
184.78 -3.14%
on 01/17/20
+51.15 (+40.01%)
since 01/24/19

Most Recent Stories

More News
Amedisys Inc Up 36.4% Since SmarTrend Uptrend Call (AMED)

SmarTrend identified an Uptrend for Amedisys Inc (NASDAQ:AMED) on October 15th, 2019 at $131.27. In approximately 3 months, Amedisys Inc has returned 36.35% as of today's recent price of $178.98.

AMED : 178.98 (-0.75%)
New Strong Buy Stocks for January 24th

New Strong Buy Stocks for January 24th

PERI : 8.29 (-5.80%)
CMRE : 7.84 (-1.01%)
CHUY : 25.15 (-0.46%)
BBL : 46.27 (-2.01%)
AMED : 178.98 (-0.75%)
Year of the Rat Spells Good Times for Wall Street: 5 Picks

Historically, during the Year of the Rat, the S&P 500's performance has been slightly better than the than the index's overall average of 11.4%.

PSTG : 19.17 (-0.42%)
MTCH : 85.57 (-3.28%)
AMED : 178.98 (-0.75%)
ENPH : 32.70 (+1.96%)
BBU : 43.12 (-0.37%)
Has Amedisys (AMED) Outpaced Other Medical Stocks This Year?

Is (AMED) Outperforming Other Medical Stocks This Year?

AMED : 178.98 (-0.75%)
The Zacks Analyst Blog Highlights: MagnaChip Semiconductor, Ichor, Chico's FAS, Amedisys and PBF Logistics

The Zacks Analyst Blog Highlights: MagnaChip Semiconductor, Ichor, Chico's FAS, Amedisys and PBF Logistics

PBFX : 21.40 (-0.65%)
ICHR : 36.36 (-3.25%)
AMED : 178.98 (-0.75%)
CHS : 4.09 (-3.99%)
MX : 14.71 (-4.91%)
Zacks.com featured highlights include: SYNNEX, MagnaChip Semiconductor, Delta Air Lines, Amedisys and Forterra

Zacks.com featured highlights include: SYNNEX, MagnaChip Semiconductor, Delta Air Lines, Amedisys and Forterra

DAL : 58.81 (-2.42%)
FRTA : 14.34 (-2.45%)
SNX : 142.78 (-1.26%)
AMED : 178.98 (-0.75%)
MX : 14.71 (-4.91%)
5 Top Stocks That Popped in 2020 and Have Strong Upside Left

It seems that Wall Street bulls have no intention of taking a breather after completing the best year in the last six years.

PBFX : 21.40 (-0.65%)
ICHR : 36.36 (-3.25%)
AMED : 178.98 (-0.75%)
CHS : 4.09 (-3.99%)
MX : 14.71 (-4.91%)
Shares of AMED Up 38.1% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Amedisys Inc (NASDAQ:AMED) on October 15th, 2019 at $131.27. In approximately 3 months, Amedisys Inc has returned 38.13% as of today's recent price of $181.32.

AMED : 178.98 (-0.75%)
Invest in These 5 Stocks With Solid Relative Price Strength

Want to try an out-of-the-box approach to earn handsome returns? Tap these stocks with explosive relative price strength.

DAL : 58.81 (-2.42%)
FRTA : 14.34 (-2.45%)
SNX : 142.78 (-1.26%)
AMED : 178.98 (-0.75%)
MX : 14.71 (-4.91%)
Elanco (ELAN) Surges: Stock Moves 5.3% Higher

Elanco (ELAN) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

AMED : 178.98 (-0.75%)
ELAN : 31.57 (-2.11%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade AMED with:

Business Summary

Amedisys, Inc. is a leading provider of healthcare in the home with a vision of becoming the premiere solution for patients. From home health to hospice to personal care, Amedisys team members provide quality, clinically-distinctive care to patients every year. Amedisys is focused on delivering the care...

See More

Key Turning Points

2nd Resistance Point 182.93
1st Resistance Point 180.95
Last Price 178.98
1st Support Level 176.56
2nd Support Level 174.15

See More

52-Week High 184.78
Last Price 178.98
Fibonacci 61.8% 154.93
Fibonacci 50% 145.71
Fibonacci 38.2% 136.50
52-Week Low 106.65

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar